These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 9200333)

  • 1. Synthesis and biological effects of N-alkylamine-labeled low-molecular-mass dermatan sulfate.
    Malsch R; Guerrini M; Berti C; Naggi A; Torri G; Casu B; Harenberg J
    Semin Thromb Hemost; 1997; 23(2):99-107. PubMed ID: 9200333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling.
    Malsch R; Guerrini M; Torri G; Löhr G; Casu B; Harenberg J
    Anal Biochem; 1994 Mar; 217(2):255-64. PubMed ID: 8203754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
    Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative.
    Harenberg J; Casu B; Guerrini M; Malsch R; Naggi A; Piazolo L; Torri G
    Semin Thromb Hemost; 2002 Aug; 28(4):343-54. PubMed ID: 12244481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
    Du HY; Ji SL; Song HF; Ye QN; Cao JC
    Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
    Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
    Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
    Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action.
    Ben Mansour M; Dhahri M; Hassine M; Ajzenberg N; Venisse L; Ollivier V; Chaubet F; Jandrot-Perrus M; Maaroufi RM
    Comp Biochem Physiol B Biochem Mol Biol; 2010 Jul; 156(3):206-15. PubMed ID: 20363356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
    Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.
    Linhardt RJ; al-Hakim A; Liu JA; Hoppensteadt D; Mascellani G; Bianchini P; Fareed J
    Biochem Pharmacol; 1991 Sep; 42(8):1609-19. PubMed ID: 1930287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
    Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
    Volpi N; Maccari F
    Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
    Halldórsdóttir AM; Zhang L; Tollefsen DM
    Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural composition and differential anticoagulant activities of dermatan sulfates from the skin of four species of rays, Dasyatis americana, Dasyatis gutatta, Aetobatus narinari and Potamotrygon motoro.
    Dellias JM; Onofre GR; Werneck CC; Landeira-Fernandez AM; Melo FR; Farias WR; Silva LC
    Biochimie; 2004; 86(9-10):677-83. PubMed ID: 15556278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
    Castañon MM; Gamba C; Kordich LC
    Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
    Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
    Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of deuterium-labeled glycosaminoglycans.
    Naggi A; Casu B; Crippa B; Magnaghi S; Silvestro L; Torri G
    Semin Thromb Hemost; 1994; 20(2):168-75. PubMed ID: 7997888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.